LPL Financial
SGMT icon

LPL Financial’s Sagimet Biosciences SGMT Stock Holding History

LPL Financial’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
26,750
+4,100
+18% +$27.9K ﹤0.01% 5734
2026
Q1 		$118K Buy
22,650
+2,076
+10% +$11.6K ﹤0.01% 5643
2025
Q4 		$122K Buy
20,574
+4,899
+31% +$35.2K ﹤0.01% 5562
2025
Q3 		$108K Buy
+15,675
New +$127K ﹤0.01% 5501
2024
Q2 		– Sell
-41,000
Closed -$222K – 5119
2024
Q1 		$222K Buy
+41,000
New +$294K ﹤0.01% 4432

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

LPL Financial's SGMT Position: Q2 2026 in Review

LPL Financial increased its Sagimet Biosciences (SGMT) stake by 18% in Q2 2026, buying an estimated $27.9K and bringing the position to 26,750 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #5734.

LPL Financial first reported a position in SGMT in Q1 2024 and has held it in 5 quarters since. The position peaked at $222K in Q1 2024. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • LPL Financial held 26,750 shares of Sagimet Biosciences worth $207K as of Q2 2026.
  • LPL Financial bought 4,100 Sagimet Biosciences shares in Q2 2026, an estimated $27.9K.
  • Sagimet Biosciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5734 holding.
  • LPL Financial first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 5 quarters since.
  • LPL Financial's Sagimet Biosciences position peaked at $222K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.